GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: RP-54476 | RP54476 | Synercid® (dalfopristin + quinupristin)
                                 dalfopristin is an approved drug (FDA (1999)) Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Dalfopristin is a semi-synthetic derivative of pristinamycin IIA (streptogramin A). It inhibits the early phase of protein synthesis in the bacterial ribosome by binding to the 70S subunit. It is administered intravenously.
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| Classification  | |
| Compound class | Synthetic organic | 
| Approved drug? | Yes. US FDA (1999) | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 6581 | dalfopristin | 
| Synonyms  | 
| RP-54476 | RP54476 | Synercid® (dalfopristin + quinupristin) | 
| Database Links  | |
| Specialist databases | |
| Antibiotic DB   | Dalfopristin | Quinupristin/dalfopristin (Synercid) | 
| Other databases | |
| CAS Registry No. | 112362-50-2 (source: WHO INN record) | 
| GtoPdb PubChem SID | 405560238 | 
| PubChem CID | 6323289 | 
| RCSB PDB Ligand | DOL | 
| Search Google for chemical match using the InChIKey | SUYRLXYYZQTJHF-VMBLUXKRSA-N | 
| Search Google for chemicals with the same backbone | SUYRLXYYZQTJHF | 
| Search PubMed clinical trials | dalfopristin | 
| Search PubMed titles | dalfopristin | 
| Search PubMed titles/abstracts | dalfopristin | 
| UniChem Compound Search for chemical match using the InChIKey | SUYRLXYYZQTJHF-VMBLUXKRSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | SUYRLXYYZQTJHF-VMBLUXKRSA-N |